Call To Action

They can apply Start-up (also Innovative, pursuant to art. 25 of Legislative Decree 18 October 2012, n.179 and subsequent amendments), Small Medium Enterprises (including Innovative pursuant to art. 4 of Legislative Decree 24 January 2015, no. 3 and subsequent amendments), University Spin-Offs, with operational headquarters in Italy and who undertake to use any funds they may receive for initiatives on Italian territory.

The “innovative start-up” is a type of business that meets the requirements indicated in article 25 and following of DL 179/2012. For more information, you can consult the following link: https://www.mise.gov.it/index.php/it/impresa/competitivita-e-nuove-imprese/start-up-innovative.

Introduced in 2015 with art. 4 of DL 3/2015, in the wake of the legislation referring to innovative start-ups, innovative SMEs represent an important nucleus of companies that contribute to the innovative development of the country. These constitute the second evolutionary stage of innovative start-ups. For more information, please consult the following link:  https://www.mise.gov.it/index.php/it/impresa/piccole-e-medie-imprese/pmi-innovative

Yes, as per the Chamber of Commerce certificate. Otherwise, the intention to open a branch in Italy, where the object of the intervention presented at the Exhibition will be developed, must be clearly stated in the business plan.

No, it is necessary that, on the date of submission of the application, the Start up has at least one approved balance sheet.

Each intervention will be assessed individually and reference will be made to the Legislative Decree 28.12.2020 Implementation methods of tax incentives under the de minimis regime for investment in innovative start-ups and innovative SMEs. (GU General Series n.38 of 02-15-2021)

This possibility is foreseeable but must be evaluated on a case-by-case basis based on the agreements that will be stipulated with the subjects who will be deemed suitable to access Phase C.

Impact refers to the extent to which the project contributes to influencing economic development, competitiveness, innovation, technology transfer, skills, completeness of supply chains, attractiveness for investments, industrial reconversion and national security in terms of productive autonomy.

As reported in section 3, within the scope of this Expression of Interest the Enea Tech and Biomedical Foundation can intervene through Equity and quasi-equity investments. No other intervention methods are foreseen.

No, it is not possible to modify or integrate the application already submitted except for the integrations requested by the Enea Tech and Biomedical Foundation.

No, only one application per applicant is permitted.

The application form includes the list of documents reported in section 5 and must be sent, complete in all its parts, only via PEC to the address: FondazioneETB.manifestazione@PEC.it.

Otherwise, at the address info.manifestazione@eneatechbiomedical.it you can request information and clarifications as indicated in section 10.

No, applications sent from non-certified email accounts will not be taken into consideration.

As reported in the section  5 of the Expression of Interest: it is requested to send the files in .pdf format in a single compressed .zip archive, the size of which must not exceed 30 Mb.

The PEC chosen for sending the application must also allow communication with natural persons. Furthermore, the PEC must be a company address.

The PEC used for the candidacy will be the official channel of communication between the protesting subjects and the Enea Tech and Biomedical Foundation.

Yes, it is possible. In this case, it is required to include an Abstract or Executive Summary in Italian in the Business Plan.